P. Soaresdasilva et al., EVIDENCE FOR THE INVOLVEMENT OF P-GLYCOPROTEIN ON THE EXTRUSION OF TAKEN UP L-DOPA IN CYCLOSPORINE-A TREATED LLC-PK1 CELLS, British Journal of Pharmacology, 123(1), 1998, pp. 13-22
1 The present work has examined the effects of short- (30 min) and lon
g-term (14 h) exposure to cyclosporine A (CsA) on the uptake of L-DOPA
, its decarboxylation to dopamine and the cellular extrusion of taken
up L-DOPA and of newly-formed amine in monolayers of LLC-PK1, cells. 2
In the presence of benserazide (50 mu M), L-DOPA was rapidly accumula
ted in LLC-PK1 cells (cultured in collagen-treated plastic) attaining
equilibrium at 30 min of incubation. Non-linear analysis of the satura
tion curves revealed a K-m, of 113+/-16 mu M and a V-max,, of 5581+/-2
97 pmol mg(-1) protein 6 min(-1). 3 In the absence of benserazide, LLC
-PK1 cells incubated with increasing concentrations of L-DOPA (10 to 5
00 mu M) for 6 min accumulate newly-formed dopamine by a saturable pro
cess with apparent K-m, and V-max,, values of 31+/-6 mu M and 1793+/-9
1 pmol mg(-1) protein 6 min(-1), respectively. The fractional outflow
of newly-formed dopamine was found to be 20%. Up to 200 mu M of intrac
ellular newly-formed dopamine, the outward transfer of the amine was f
ound to be a non-saturable process. 4 Short-term exposure to CsA (0.3,
1.0 and 3.0 mu g ml(-1)) was found not to change the intracellular co
ncentrations of newly-formed dopamine, but increased the levels of dop
amine in the incubation medium (143% to 224% increase) and the total a
mount of dopamine formed (31% to 59% increase). Long-term exposure to
CsA (0.03 to 3.0 mu g ml(-1)) reduced the total amount of dopamine (15
% to 39% reduction) and the intracellular levels of the amine (11% to
56% reduction), without changing dopamine levels in the incubation med
ium. Both short-and long-term exposure to CsA resulted in a concentrat
ion-dependent increase in the fractional outflow of newly-formed dopam
ine. 5 Short-term exposure to CsA (3.0 mu g ml(-1)) reduced the apical
extrusion of intracellular L-DOPA by 15% (P<0.05), whereas long-term
exposure to CsA reverted this effect and decreased its intracellular a
vailability (15% reduction; P<0.05). 6 Detection of P-glycoprotein act
ivity was carried out by measuring verapamil-or UIC2-sensitive rhodami
ne 123 accumulation. Both UIC2 (3 mu g ml(-1)) and verapamil (25 mu M)
significantly increased the accumulation of rhodamine 123 in LLC-PK1
cells. A 30 min exposure to CsA was found not to affect the accumulati
on of rhodamine 123 in the presence of verapamil (25 mu M), whereas a
14 h exposure to CsA was found to reduce the accumulation of rhodamine
123. 7 In conclusion, the increase and the reduction in the formation
of dopamine after short-and long-term exposure to CsA, respectively,
correlate with the effects of the immunosuppressant on the apical cell
extrusion of taken up L-DOPA, suggesting the involvement of P-glycopr
otein. The effects of CsA on the fractional outflow of newly-formed do
pamine appear to be mediated by a different mechanism.